USPTO serial 79260638
QLETLI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 7, 2020
- Examiner
- LAVACHE, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with QLETLI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CN
Science City, Guangzhou, CN
Science City, Guangzhou, CN
Science City, Guangzhou, CN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Zhi Dong
Zhi Dong Hamre, Schumann, Mueller & Larson, P.C.45 South Seventh Street, Suite 2700Minneapolis, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in humans for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bio-Thera Solutions, Ltd.
- Other trademarks owned by Bio-Thera Solutions, Ltd.
- Other trademarks owned by Bio-Thera Solutions, Ltd.
- Other trademarks owned by Bio-Thera Solutions, Ltd.
- Other trademarks in Class 005
- Similar marks named QLETLI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 29, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 7, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 29, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 12, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 12, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 7, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 7, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 13, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 13, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 13, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 13, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 13, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 13, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 4, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 16, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 16, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 24, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 23, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 18, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 18, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 13, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |